Towa Pharmaceutical forecasts 1H net sales at JPY 145.7 billion

• Towa Pharmaceutical set a first-half plan of JPY 145.7 billion net sales, JPY 12.7 billion operating profit, JPY 11.7 billion ordinary profit.
• It also targets JPY 53.7 billion gross profit, JPY 8.1 billion profit attributable to owners of parent.
• First-quarter progress rates ran at 49% for sales, 51.3% for operating profit, 67.9% for ordinary profit.
• Ordinary profit benefited from a JPY 1.4 billion gain on valuation of derivatives, versus a JPY 1.4 billion loss a year earlier.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TOWA Pharmaceutical Co. Ltd. published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.